Matches in Nanopublications for { ?s ?p "[Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP892553.RABcPfGjcHMso699HKRCXLUoht5FpEJMDb3ywp0uzmNs4130_assertion description "[Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892553.RABcPfGjcHMso699HKRCXLUoht5FpEJMDb3ywp0uzmNs4130_provenance.
- assertion description "[Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP892554.RAgFUJBhAQvPX9JetQrJT91SR0DWbAUzYev9GcF_dl1Cw130_assertion description "[Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892554.RAgFUJBhAQvPX9JetQrJT91SR0DWbAUzYev9GcF_dl1Cw130_provenance.